Showing results (881-890 of 975) with videos related to

Sort By:
Pageof 98
AJNR. American Journal of Neuroradiology|August 3, 2013
Imaging recommendations for acute stroke and transient ischemic attack patients: A joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional SurgeryM Wintermark, P C Sanelli, G W Albers, et al.
Iscience|August 22, 2022
EZH2 T367 phosphorylation activates p38 signaling through lysine methylation to promote breast cancer progressionMaria E Gonzalez, Giuseppina Daniela Naimo, Talha Anwar, et al.
British Journal of Clinical Pharmacology|December 12, 2019
Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathyLauren A Marcath, Kelley M Kidwell, Kiran Vangipuram, et al.
Cell Stem Cell|June 3, 2018
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic LeukemiaMichael Y Choi, George F Widhopf, Emanuela M Ghia, et al.
Circulation. Cardiovascular Quality and Outcomes|May 16, 2023
Reach Out Emergency Department: A Randomized Factorial Trial to Determine the Optimal Mobile Health Components to Reduce Blood PressureLesli E Skolarus, Mackenzie Dinh, Kelley M Kidwell, et al.
American Heart Journal|August 17, 2019
Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD)Nwora Lance Okeke, Allison R Webel, Hayden B Bosworth, et al.
Plos One|November 15, 2021
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancerElizabeth P Darga, Emily M Dolce, Fang Fang, et al.
BMJ Global Health|June 9, 2026
Progress in family planning in Sierra Leone: a mixed-methods case studyPhilip S Amara, Mohamed Kanu, Alhassan Kanu, et al.
Neurology|September 9, 2011
Secondary preventive medication persistence and adherence 1 year after strokeC D Bushnell, D M Olson, X Zhao, et al.
Breast Cancer Research and Treatment|April 3, 2013
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancerN Lynn Henry, Todd C Skaar, Jessica Dantzer, et al.
Pageof 98